Brain PET-MRI Systems Market Size & Growth Forecast 2026–2035, By Segments (Phase, Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Brain PET-MRI Systems Market size was valued at USD 378.58 Million in 2025 and is projected to grow at a 6.1% CAGR from 2026 to 2035, attaining USD 684.4 Million by 2035. The industry revenue for 2026 is estimated at USD 398.69 million.

• Base Year Value (2025): USD 378.58 Million
• CAGR (2026-2035): 6.1%
• Forecast Year Value (2035): USD 684.4 Million
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Brain PET-MRI Systems Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held a 32.22% market share in 2025, supported by advanced diagnostic imaging infrastructure, widespread use of multimodal neuroimaging, and strong deployment across hospitals, research centers, and specialized imaging facilities.
  • Asia Pacific is projected to grow at a 6.89% CAGR as healthcare providers expand advanced imaging capacity, invest in modern diagnostic equipment, and improve access to specialized neurological evaluation.

• Segment Momentum:

  • Pre-clinical leads with 60.9% due to strong use in neuroscience research, translational studies, and established experimental imaging workflows requiring integrated PET-MRI for controlled studies and long development cycles.
  • Helium-free PET-MRI systems are fastest-growing due to reduced reliance on helium cooling, lower operational constraints, improved sustainability, and easier long-term maintenance, supporting broader adoption in clinical and research facilities.

• Market Expansion Drivers:

  • Growing adoption of hybrid neuroimaging systems improving functional and structural brain diagnostics.
  • Rising demand for ultra-high-resolution imaging enhancing neurological research and diagnosis precision.
  • Increasing clinical integration of multiparametric imaging for early detection of neurological disorders.

• Leading Market Participants:

  Major players in the brain PET-MRI systems market include Siemens Healthineers AG (Germany), GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Mediso Ltd. (Hungary), MR Solutions Ltd. (United Kingdom), Cubresa Inc. (Canada), United Imaging Healthcare Co., Ltd. (China).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 378.58 Million
  • Projected Market Size: USD 684.4 Million by 2035
  • Growth Forecasts: 6.1% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Pre-clinical (Phase) | Traditional PET-MRI Systems (Product) | Hospitals (End-use)
  • Emerging Opportunity Segment: Clinical (Phase) | Helium-free PET-MRI Systems (Product) | Diagnostic Imaging Centers (End-use)

Market Growth Drivers and Industry Trends

Growing adoption of hybrid neuroimaging systems improving functional and structural brain diagnostics

As hospitals, academic medical centers, and specialized neurology institutes seek to reduce the tradeoff between metabolic insight and anatomical detail, hybrid platforms are gaining preference over separate imaging workflows. In the brain PET-MRI systems market, This trend is influencing market adoption by making a single-session exam more clinically attractive for complex neurological cases where lesion localization, tissue characterization, and functional assessment need to be interpreted together. Procurement decisions increasingly favor systems that can streamline diagnostic pathways, reduce image misregistration between modalities, and support closer collaboration between radiology, nuclear medicine, and neurology teams, driving demand for the market through clearer clinical utility rather than standalone equipment replacement.

Rising demand for ultra-high-resolution imaging enhancing neurological research and diagnosis precision

Demand for sharper visualization of small brain structures and subtle pathological changes is driving market development as researchers and clinicians push for imaging tools that improve confidence in detecting early-stage abnormalities. The brain PET-MRI systems market benefits because PET-MRI combines high soft-tissue contrast with functional mapping, making it well suited for applications where conventional imaging may miss low-volume lesions, microstructural changes, or nuanced disease patterns. This is contributing to market size growth by aligning with research priorities in neurodegeneration, epilepsy, and brain oncology, while also supporting clinical centers that want more precise imaging capabilities to differentiate overlapping neurological conditions.

Increasing clinical integration of multiparametric imaging for early detection of neurological disorders

Clinical practice is moving toward imaging strategies that combine metabolic, perfusion, diffusion, and structural information to identify disease earlier and characterize it more reliably before symptoms become advanced. That trend is reinforcing market demand for the brain PET-MRI systems market because these systems enable multiparametric assessments in a unified workflow, helping physicians correlate complementary biomarkers without relying on separate appointments and post hoc image fusion. The practical effect is stronger interest from centers building advanced neurology pathways, where earlier detection of neurodegenerative and other brain disorders depends on integrating several imaging parameters into treatment planning and longitudinal patient management.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Growing adoption of hybrid neuroimaging systems improving functional and structural brain diagnostics	2.30%	High	North America, Europe	Medium	Mid Term
Rising demand for ultra-high-resolution imaging enhancing neurological research and diagnosis precision	2.00%	Moderate	North America, Europe, Asia Pacific	Emerging	Mid Term
Increasing clinical integration of multiparametric imaging for early detection of neurological disorders	1.80%	High	North America, Europe	Medium	Long Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 32.22% share of the brain PET-MRI systems market in 2025, backed by its established base of advanced diagnostic imaging infrastructure and routine integration of high-end neuroimaging in clinical and research settings. The region’s leadership is reinforced by the concentration of hospitals, academic medical centers, and specialized imaging facilities that are better positioned to deploy hybrid systems for complex neurological assessment, while strong familiarity with multimodal imaging workflows helps sustain utilization in practice.

Asia Pacific is projected to expand at a 6.89% CAGR over the forecast period, with growth in the brain PET-MRI systems market being impelled by the gradual expansion of advanced imaging capacity across major healthcare systems. Demand is accelerating as providers increase investment in modern diagnostic equipment and as access to specialized neurological evaluation improves, particularly in settings where healthcare infrastructure upgrades are enabling broader adoption of sophisticated hybrid imaging technologies.

Key Country Insights

United States

Advanced Neuroimaging Adoption

The U.S. prioritizes brain PET-MRI systems for neurological research, precision diagnostics, and academic medical centers. Demand is supported by integration with advanced imaging workflows and increasing emphasis on early detection of complex brain disorders.

Japan

Precision Brain Diagnostics

Japan advances brain PET-MRI systems through strong interest in neurodegenerative disease assessment and high-quality imaging performance. Healthcare providers seek technologies that improve diagnostic accuracy while fitting established hospital imaging infrastructure.

South Korea

Research Hospital Expansion

South Korea expands adoption of brain PET-MRI systems across major research hospitals investing in advanced diagnostic capabilities. Clinical institutions prioritize integrated imaging platforms that support neuroscience innovation and personalized treatment planning.

Germany

Clinical Imaging Integration

Germany emphasizes brain PET-MRI systems that strengthen collaboration between university hospitals and imaging specialists. Procurement focuses on improving diagnostic confidence while supporting multidisciplinary neuroscience and oncology programs.

France

Translational Imaging Focus

France promotes brain PET-MRI systems within research-driven healthcare networks focused on neurological and oncological applications. Investment supports collaboration between clinical practice and translational research to enhance diagnostic workflows.

Italy

Specialized Imaging Investment

Italy focuses on brain PET-MRI systems for specialized hospitals seeking comprehensive neurological imaging capabilities. Healthcare providers value systems that improve clinical efficiency while supporting complex diagnostic case management.

Segment Leadership and Growth Trends

  Phase Segment Analysis: Pre-clinical (Largest Segment) vs Clinical (Fastest-Growing Segment)

The Pre-clinical phase held the leading position in the brain PET-MRI systems market in 2025, accounting for a 60.9% share. Its leadership is maintained through the established use of brain PET-MRI systems in early-stage neuroscience and translational research, where integrated metabolic and anatomical imaging is especially valuable for controlled experimental studies. Pre-clinical environments also tend to support longer development cycles and specialized imaging workflows, which helps preserve demand for these systems and reinforces the segment’s dominant share.

Clinical is the fastest-growing phase in the brain PET-MRI systems market as healthcare providers and research-linked hospitals increasingly seek more advanced neuroimaging tools for patient-centered applications. Growth is being underpinned by the practical shift from research-only use toward clinical evaluation, where the combined capabilities of PET and MRI can improve diagnostic workflow and support more comprehensive brain assessment. Compared with pre-clinical settings, the Clinical segment is gaining momentum as adoption broadens into real-world care environments with expanding demand for integrated imaging solutions.

Product Segment Analysis: Traditional PET-MRI Systems (Largest Segment) vs Helium-free PET-MRI Systems (Fastest-Growing Segment)

Traditional PET-MRI Systems remained the largest product segment in the brain PET-MRI systems market in 2025, with a 58.59% share. This leadership reflects their entrenched presence across existing imaging installations and the familiarity of institutions with conventional system architecture, operating requirements, and performance expectations. The segment continues to hold the largest share because purchasing decisions in this market often favor proven equipment platforms that align with established infrastructure, technical expertise, and ongoing research or diagnostic workflows.

Helium-free PET-MRI Systems are emerging as the fastest-growing product segment in the brain PET-MRI systems market, driven by the market’s increasing preference for systems that reduce operational dependency on helium-based cooling. Their momentum relative to traditional PET-MRI systems comes from the practical appeal of lowering supply-related constraints and easing long-term maintenance considerations, especially for facilities looking to improve system sustainability and operational resilience. As buyers place greater weight on lifecycle efficiency, helium-free configurations are experiencing stronger uptake faster than conventional alternatives.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Phase	Clinical, Pre-clinical	Pre-clinical	Clinical
Product	Traditional PET-MRI Systems, Helium-free PET-MRI Systems	Traditional PET-MRI Systems	Helium-free PET-MRI Systems
End-use	Hospitals, Diagnostic Imaging Centers, Others	Hospitals	Diagnostic Imaging Centers

Competitive Landscape and Market Positioning

Prominent players in the brain PET-MRI systems market:

1. Siemens Healthineers AG (Germany)

2. GE HealthCare Technologies Inc. (United States)

3. Koninklijke Philips N.V. (Netherlands)

4. Mediso Ltd. (Hungary)

5. MR Solutions Ltd. (United Kingdom)

6. Cubresa Inc. (Canada)

7. United Imaging Healthcare Co. Ltd. (China)

The brain PET-MRI systems market is advancing through integration of hybrid imaging technologies that improve neurological diagnostic precision. Continuous innovation is enhancing image resolution and functional analysis capabilities. Collaborative research efforts are strengthening multimodal imaging applications in neuroscience.

Industry Development/News

Company Name	Date	Key Development
GE HealthCare	May-24	GE HealthCare introduced SIGNA MAGNUS, a head-only MRI system designed to advance neuroscience research and improve understanding of brain structure and function. The system is positioned to support research into psychiatric and neurological disorders by enabling higher-resolution imaging and more targeted investigation of complex brain conditions in clinical and research environments.
Philips	Feb-24	Philips launched Smart Quant Neuro 3D, an AI-based quantitative brain MRI software solution aimed at improving diagnostic confidence and workflow efficiency. The solution enhances image interpretation capabilities in neuroimaging by providing advanced quantitative tools for more precise assessment of neurological conditions.
GE HealthCare	Jun-23	GE HealthCare unveiled SIGNA PET/MRI AIR technologies at the Society of Nuclear Medicine and Molecular Imaging annual meeting, introducing enhancements to hybrid imaging performance. The development strengthens its PET-MRI portfolio by improving image quality and system integration for advanced neuroimaging applications in clinical and research settings.
Cubresa	May-23	Cubresa installed its first BrainPET insert system at St. Joseph’s Health Care London in collaboration with Lawson Health Research Institute. The installation validates the system in a real-world research environment and supports advancement of hybrid brain imaging technologies by enabling integrated PET-MRI research applications.